Prudential Financial Inc. Boosts Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Prudential Financial Inc. boosted its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 7.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 82,059 shares of the medical instruments supplier's stock after purchasing an additional 5,795 shares during the period. Prudential Financial Inc. owned about 0.34% of ICU Medical worth $12,733,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in ICUI. FMR LLC lifted its holdings in shares of ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock valued at $18,968,000 after buying an additional 100,345 shares during the period. State Street Corp raised its position in ICU Medical by 9.3% during the third quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier's stock valued at $165,384,000 after acquiring an additional 77,506 shares in the last quarter. Raymond James Financial Inc. acquired a new position in ICU Medical in the fourth quarter valued at approximately $10,003,000. Geode Capital Management LLC boosted its position in ICU Medical by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier's stock worth $99,687,000 after purchasing an additional 48,106 shares in the last quarter. Finally, Proficio Capital Partners LLC purchased a new position in shares of ICU Medical during the 4th quarter valued at approximately $5,779,000. 96.10% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Ratings Changes

ICUI has been the topic of a number of recent analyst reports. Raymond James set a $97.00 price target on shares of ICU Medical in a report on Wednesday, March 12th. StockNews.com cut ICU Medical from a "buy" rating to a "hold" rating in a research report on Thursday, March 27th. Finally, Jefferies Financial Group upgraded ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $168.67.

Insider Buying and Selling

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at $16,262,119.64. The trade was a 1.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 6.70% of the stock is currently owned by insiders.

ICU Medical Price Performance

Shares of NASDAQ ICUI traded down $1.06 during trading on Tuesday, hitting $137.80. The company had a trading volume of 327,717 shares, compared to its average volume of 262,554. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock has a fifty day simple moving average of $153.34 and a two-hundred day simple moving average of $163.24. The firm has a market capitalization of $3.38 billion, a price-to-earnings ratio of -30.15 and a beta of 0.73.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.